PND74 How Have Manufacturers Overturned Negative Reimbursement Decisions? A Case Study Using Natalizumab for Multiple Sclerosis
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1998
https://www.valueinhealthjournal.com/article/S1098-3015(12)03711-4/fulltext
Title :
PND74 How Have Manufacturers Overturned Negative Reimbursement Decisions? A Case Study Using Natalizumab for Multiple Sclerosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03711-4&doi=10.1016/j.jval.2012.08.1998
First page :
A559
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
1486